RNA-Seq Innovators. Precision Transcriptomics for Advanced NGS Applications.
Lexogen GmbH is an Austria based biotechnology company globally recognized as a leader in RNA sequencing (RNA-Seq) innovation. Uniquely focused on transcriptomics, Lexogen develops cutting-edge tools that enable scientists to deeply explore gene expression, regulation, and alternative transcription.
Lexogen provides complete solutions from sample preparation to data analysis, specifically optimized for Next-Generation Sequencing (NGS) workflows. Their unique library preparation technologies are designed for low-input, challenging RNA samples—allowing precise analysis of low-abundance transcripts, long non-coding RNAs, viral RNA, and degraded or clinical RNA.
Key Solutions and Applications:
- QuantSeq 3’ mRNA-Seq: a rapid and cost effective method for gene expression profiling, focusing on the 3’ end of transcripts.
- CORALL Total RNA-Seq: a comprehensive solution for analyzing both coding and non-coding RNA in a single workflow.
- Single Cell & Low Input RNA-Seq: ultra sensitive solutions ideal for limited samples, including rare cells and clinical specimens.
- Spike-In Controls: standardized reference reagents for quality control, reproducibility, and accurate quantification.
Innovation and Use Cases:
Lexogen’s technologies are widely used for:
Gene expression studies
Biomarker discovery
Immunology and neuroscience research
Drug development and personalized medicine
Their platforms are valued for:
Streamlined workflows
Minimal sample degradation
High specificity and sensitivity
Lexogen’s technologies are cited in hundreds of peer-reviewed publications and trusted by leading universities, research institutions, and biotech companies worldwide. If your research demands precision and innovation at the RNA level, Lexogen is a trusted partner for RNA-Seq-based NGS studies.